OGN - CIK 0001821825
The table below shows Organon & Co.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.12B | $672.00M | $599.00M | $547.00M | $763.00M | $704.00M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $1.38B | $1.48B | $1.48B | $1.46B | $1.69B | $1.62B |
| Inventory | $1.37B | $1.49B | $1.45B | $1.36B | $1.38B | $1.29B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $4.93B |
| $4.70B |
| $4.62B |
| $4.37B |
| $4.76B |
| $4.51B |
| Property, plant & equipment | $1.28B | $1.29B | $1.27B | $1.20B | $1.20B | $1.16B |
| Goodwill | $4.15B | $4.68B | $4.68B | $4.68B | $4.60B | $4.60B |
| Total assets | $13.00B | $13.55B | $13.50B | $13.16B | $12.75B | $12.15B |
| Accounts payable | $983.00M | $1.07B | $1.07B | $1.01B | $1.09B | $1.24B |
| Total current liabilities | $2.50B | $2.68B | $2.80B | $2.62B | $2.79B | $2.75B |
| Long-term debt | $8.55B | $8.78B | $8.78B | $8.94B | $8.74B | $8.65B |
| Total liabilities | $12.09B | $12.65B | $12.77B | $12.61B | $12.26B | $12.01B |
| Retained earnings | $1.25B | $1.32B | $1.16B | $1.03B | $975.00M | $690.00M |
| Total equity | $903.00M | $906.00M | $733.00M | $542.00M | $493.00M | $144.00M |